Pharmacogenomics of Cancer
Pharmacogenomics of Cancer
Frank McCormick discusses how each protein is a problem in the use of pharmaceutics to combat cancer and suggests that d... Read more
14 May 2009
•
Hedgehog Signaling and Cancer: New Concepts and Therapeutic Opportunities
Hedgehog Signaling and Cancer: New Concepts and Therapeutic Opportunities
Anthony Oro, MD, PhD, discusses how Hedgehog signally is a model for a variety of morphogenetic signals, that taking ste... Read more
14 May 2009
•
Hodgkin's Disease: A Paradigm for Clinical Research
Hodgkin's Disease: A Paradigm for Clinical Research
Dr. Saul Rosenberg discusses the history of diagnosis and treatment of Hodgkin's Disease and the remarkable improvement ... Read more
14 May 2009
•
Targeted Anticancer Therapies
Targeted Anticancer Therapies
Stanford's Branimir Sikic discusses the importance of, and offers guidance to achieve the development of personalized me... Read more
14 May 2009
•
Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer
Chromosomal Aberrations: Entrees to Core Pathways and Biomarkers in Cancer
Dr. Michael Cleary discusses this work on the role of chromosomal aberrations in causing cancer and its implications for... Read more
14 May 2009
•
Gynecologic Cancers: Translational Research Opportunities
Gynecologic Cancers: Translational Research Opportunities
Dr. John K. Chan, gyncecologic cancer specialist at the University of California - San Francisco Medical Center, discuss... Read more
14 May 2009
•
Translational Research in Acute Leukemia
Translational Research in Acute Leukemia
Dr. Linda M. Boxer discusses her research on acute leukemia. (September 18, 2008)
14 May 2009
•
Translational Cancer Research in Urological Malignancies
Translational Cancer Research in Urological Malignancies
Dr. James Brooks discusses his work on screening for and treatment of prostate cancer. (September 18, 2008)
14 May 2009
•
Imaging of Immune Cell Trafficking Patterns Refines Development of Cell-Based Therapies
Imaging of Immune Cell Trafficking Patterns Refines Development of Cell-Based Therapies
Professor Christopher Contag discusses immune cell trafficking patterns as they relate to recognition of minimal residua... Read more
14 May 2009
•
Assessing Genetic Risk for Cancer: Stanford Clinical Cancer Genetics Program
Assessing Genetic Risk for Cancer: Stanford Clinical Cancer Genetics Program
Dr. James Ford, Associate Professor of Medicine and Genetics at the Stanford University School of Medicine, discusses po... Read more
14 May 2009
•